Nickel-catalyzed cross coupling produces N-benzyl heterocycles, suggesting efficient synthesis methods for bioactive compounds.
A nickel‐catalyzed system is developed that enables the coupling between aryldibenzothiophenium salts and N ‐alkenyl heterocycles. Traditionally, medicinally relevant N ‐benzylic heterocycles are constructed via harsh substitution conditions between the N‐H heterocycle and a benzyl electrophile in the presence of strong bases. The CC cross coupling strategy presents attractive potential for the synthesis of these important scaffolds, e.g., carboetomidate. Herein, it is documented that the combination of a site‐selective CH dibenzothiophenation with a nickel‐catalyzed C(sp 3 )–C(sp 2 ) cross coupling grants access to a diverse range of synthetically useful N ‐benzylic heterocycles, i.e., alkylated arenes. In particular, the mild conditions and good functional group compatibility permit the rapid assembly of molecular complexity and late‐stage functionalization of bioactive compounds, such as clofibrate, fenofibrate, and fenbufen, thus providing an orthogonal protocol to existing S N 2 and CN coupling approaches.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: